Court Orders CH Biotech to Pay Chunghwa Telecom NT$4.5 Million

MT Newswires Live11:35

CH Biotech R&D (TPE:6534) was ordered by the Taiwan Nantou District Court to pay Chunghwa Telecom (TPE:2412) NT$4.5 million plus interest in a civil litigation case, according to a Tuesday Taiwan Stock Exchange filing.

The dispute stemmed from two project contracts the companies signed in 2017 for the CH Biotech new factory and office low-voltage engineering project and a personnel control system implementation project.

CH Biotech said defects were identified during and after construction and that it repeatedly notified Chunghwa Telecom to rectify them, but the systems remained unable to function normally, preventing formal acceptance.

The company said its operations and financial condition remain normal and that it has retained legal counsel to appeal the judgment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment